Heart failure is a common medical condition, with new treatment approaches being developed every day. By 2030, an estimated 8 ...

Novo Nordisk has shared positive results from a late-stage study of its investigational haemophilia A therapy Mim8 in ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...

Healthcare professionals (HCPs) are increasingly seeking flexibility and convenience in their interactions with ...

Inizio has announced that it has appointed Colin Stanley as its new chief commercial officer. Stanley brings over 30 years of ...

Ultimately, transformation isn’t about technology or processes – it’s about people. The organisations investing in their ...

The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the immunotherapy be approved to treat adults ...

Today Accession Healthcare Consulting Ltd (Accession) has announced the achievement of a major consulting milestone as it ...

LEO Pharma and non-profit organisation DEBRA Research have announced a collaboration aimed at accelerating the development of treatments for epidermolysis bullosa (EB). The non-exclusive strategic ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...